Tetragon Partners GP Ltd
Q3 2026 13F-HR Holdings
Net value change ($000)
+130,901
(20.6%)
New positions
5
Sold out positions
4
Turnover %
4.8%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q2 2026
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| PATH | 80,873 | 24.0% |
| SLN | 18,234 | 217.3% |
| PHVS | 16,366 | 160.1% |
| IONS | 11,983 | 155.5% |
| KGEI | 8,414 | 24.9% |
| NBIX | 6,668 | NEW |
| ARWR | 6,645 | 62.5% |
| AXSM | 6,454 | NEW |
| UBER | 4,894 | NEW |
| AUTL | 3,230 | 21.3% |
Top Reduces (Value $000, Stocks/ETFs)
| AMLX | -5,351 | -100.0% |
| ANNX | -4,319 | -60.9% |
| ACAD | -4,247 | -100.0% |
| CUE BIOPHARMA INC | -2,961 | -100.0% |
| RLAY | -2,598 | -24.3% |
| ACRS | -2,116 | -100.0% |
| ALKT | -1,978 | -18.2% |
| DFTX | -1,667 | -12.3% |
| ALKERMES PLC | -1,575 | -15.8% |
| CLDX | -1,216 | -11.3% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
8,463
(1.1% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|